UpFront
.jpg?impolicy=website&width=800&height=600 "China moves to tighten its control of Hong Kong")
-
Global disinflation in retreat
Expect Indian inflation to stay within the 4-6 percent range, say experts
-
Episode 14: What are the chances your company will survive Covid-19?
On this episode, 'dean of valuation' Aswath Damodaran discusses his book 'Narrative and Numbers', shedding light on valuing companies during the pandemic and what this means for markets like India
-
#Wanderlost? What the future of travel will look like
How the coronavirus will cause the travel bug to mutate
-
We have serious doubts on resources to achieve SDGs: UN's Satya Tripathi
United Nations' Assistant Secretary General, Satya Tripathi, spoke to Forbes India about sustainable development goals in the post Covid-19 world, and why we need to weigh out the true costs of future investments
-
RBI cuts interest rates further by 40 bps; extends moratorium on loans
Experts say that more needs to be done after Shaktikanta Das's briefing on Friday, and that special dispensation is needed for restructuring loans to worst-hit sectors
-
Facebook starts planning for permanent remote workers
Mark Zuckerberg, Facebook's chief executive, told workers during a staff meeting that was livestreamed on his Facebook page that within a decade, as many as half of the company's more than 48,000 employees would work from home
-
China abandons growth target for 2020 as coronavirus disrupts economy
The decision comes as China's top leaders gathered in Beijing to set the country's priorities for the coming year
-
Mental health and Covid-19: Mind Matters, episode 1 with Raj Mariwala
Raj Mariwala, director, Mariwala Health Initiative, talks about the importance of self-awareness to identify triggers, and how to ensure people at the margins and on the frontlines have their mental health looked after during the Covid-19 pandemic
-
Jio bags fifth investment, from KKR
In the last month, Mukesh Ambani-owned Jio Platforms has raised $10.3 billion or Rs 78,562 crore
-
Podcast: The race to make a Covid-19 vaccine in India
It typically takes five years (and about Rs 15 crore for just the first of many phases) to introduce a viable vaccine to market. Companies across India such as Zydus Cadila, Serum Institute and Bharat Biotech are working against the clock to shrink this period down to a few months. Forbes India's Divya Shekhar takes a deep dive into what this rush looks like on the ground and gives us a glimpse into the path ahead in this episode
-
C-CAMP helps commercialise 17 innovations fighting Covid-19, more in pipeline
The Bengaluru-based accelerator has created a dedicated programme to support Indian startups that are aimed at fighting the pandemic, which received over a thousand applications